Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Only routine metadata updates are visible, such as updated last-update dates and timestamps; core content, eligibility criteria, endpoints, and participation instructions remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:31:08.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Updated biosimilar names and related dates; removed older date entries to reflect current information.
    Difference
    2%
    Check dated 2025-10-20T05:45:59.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T17:18:39.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Update: version from v3.0.2 to v3.1.0, indicating a new release.
    Difference
    0.0%
    Check dated 2025-09-28T10:09:17.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    No significant content changes detected; the page only upgrades the revision from v3.0.1 to v3.0.2 and removes the 'Back to Top' element.
    Difference
    0.1%
    Check dated 2025-09-14T00:21:01.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T21:18:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.